Cancer immunotherapeutic agents can be tumour-targeted to improve their therapeutic efficacy. Here the authors engineer Salmonella typhimurium loaded with cytolysin A and flagellin B to potentiate its anti-tumour activity in primary and metastatic tumours.
- Dinh-Huy Nguyen
- Sung-Hwan You
- Jung-Joon Min